company

Moderna

Moderna is a company that develops medicines and vaccines based on mRNA science. It was known as ModeRNA Therapeutics from 2010 to 2018. Its mission is to create a new generation of transformative medicines for patients.

modernatx.com

Chief Executive Officer

Stéphane Bancel

Key facts

Founded: September 2010source
Nasdaq IPO, December 7, 2018: raising $621 million by selling 27 million shares at $23 per sharesource
CEPI funding for Bundibugyo ebolavirus vaccine candidate (mRNA-1469): up to US$50 millionsource
First dose in Phase 1 trial of mRNA-1469: August 3, 2026, in Truro, Nova Scotiasource
Mission: deliver on the promise of mRNA science to create a new generation of transformative medicines for patientssource

WYDE coverage of Moderna

Newsletter

A Judge Ordered Meta to Pay $567 Million, Another Gave HHS Until Noon, and the Farm Bill Died by One Vote. Over 63,000 Meals.

Aug 8, 2026 · 8 min read

Innovation

Moderna Doses First Patient in a Bundibugyo Ebola Vaccine Trial as Congo Deaths Pass 1,700

Aug 6, 2026 · 3 min read

Sources

Track the institutions that move money.

Data-driven coverage every Friday.